Dislog Group continues to expand its footprint in the healthcare sector with the signing of a definitive agreement to acquire 100% of Eramedic’s share capital. The transaction, concluded with shareholders 3P Fund and Impulsia, marks a major strategic move for the Moroccan conglomerate.
Through its dedicated subsidiary, Dislog Dispositifs Médicaux (DDM), the group will integrate Eramedic into a fast-growing portfolio of healthcare-focused entities, including Megaflex, Farmalac, Africare (soon to become Afrobiomedic). The acquisition is part of Dislog’s broader ambition to become a national leader in medical devices and an all-in-one provider of healthcare technology solutions.
“Our goal is to become a One Stop Shop across all therapeutic areas and deliver full End-to-End services,” stated Dislog Group Chairman Moncef Belkhayat.
Founded in 1976, Eramedic is a recognized leader in hospital engineering and the distribution of high-tech medical devices. The company represents top global brands such as Medtronic, Karl Storz, and Fujifilm. Current CEO Karim Haj Riffi will continue to lead the company to ensure a seamless transition and future growth within the new structure.
The transaction is pending regulatory approval from Morocco’s Competition Council. Dislog was advised by Fintrust Capital (M&A) and legal counsel Maître Rachid Hilmi, while Majorelle Capital advised the selling shareholders.
